Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 12, 2024 16:05 ET | Source: Surrozen, Inc.

Surrozen Provides Second Quarter 2024 Financial Results and Business Update

Surrozen Provides Second Quarter 2024 Financial Results and Business Update
June 04, 2024 08:30 ET | Source: Surrozen, Inc.

Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis

Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis
April 03, 2024 08:40 ET | Source: Surrozen, Inc.

Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis

Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis
April 01, 2024 08:30 ET | Source: Surrozen, Inc.

Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043

Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043
January 18, 2024 08:30 ET | Source: Surrozen, Inc.

Surrozen Provides Corporate Update on Clinical Programs

Announces strategic prioritization of clinical programs to focus on development of SZN-043 for Alcohol-Associated Hepatitis SZN-043- Completed enrollment for the Phase 1a clinical trial in chronic...
November 08, 2023 16:05 ET | Source: Surrozen, Inc.

Surrozen Provides Third Quarter 2023 Financial Results

Expect to announce data from SZN-043 Phase 1a clinical trial in patients with chronic liver disease and in healthy volunteers in Q1 2024 Expect to announce data from SZN-1326 Phase 1a clinical...